A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma
Status:
Recruiting
Trial end date:
2026-06-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label single-arm phase II study to evaluate the efficacy and
safety of Zimberelimab (GLS-010) combined with AVD for newly diagnosed early-stage Hodgkin's
lymphoma under the guidance of PET/CT.